A2A Pharmaceuticals, Inc.
SEC CIK 1859061 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMEA | Biomea Fusion, Inc. | 10% | 3.55M | -$45.7K | $20.30M | 10 | 2021-09-17 | 2023-05-31 |
Most active insiders at BMEA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hitchcock Michael J.M. | Interim CEO, Dir | $99.0K | — |
| 2 | Erdtmann Rainer M | See Remarks, Dir | $97.4K | — |
A2A Pharmaceuticals, Inc. made no open-market trades at BMEA in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-02 | 2023-05-31+ | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.11 | -125.0K | 3.55M | -3% | -$4.26M |
| 2023-05-17 | 2023-05-12 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $33.84 | -25.0K | 3.62M | -0.7% | -$846.0K | |
| M | 2023-05-10 | 2023-05-08+ | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.30 | -250.0K | 3.65M | -6% | -$8.57M |
| 2023-04-26 | 2023-04-20 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $29.12 | -200.0K | 3.90M | -5% | -$5.82M | |
| A | 2023-04-06 | 2023-03-31 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $31.25 | -200.0K | 4.10M | -5% | -$6.25M |
| 2023-04-06 | 2023-03-31 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $31.25 | +200.0K | 4.10M | +5% | +$6.25M | |
| 2022-08-19 | 2022-08-16 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | P - Purchase | $13.87 | -30.7K | 4.30M | -0.7% | -$425.6K | |
| 2022-07-25 | 2022-07-21 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $11.21 | -34.7K | 4.33M | -0.8% | -$388.5K | |
| 2022-06-28 | 2022-06-24 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $11.76 | -34.7K | 4.37M | -0.8% | -$407.6K | |
| 2021-09-21 | 2021-09-17 | BMEA | Biomea Fusion, Inc. | A2A Pharmaceuticals, Inc. | 10% | P - Purchase | $10.96 | +34.7K | 4.40M | +0.8% | +$379.9K |
Purchase Sale Sale after option exercise All abbreviations